Pozen settles Treximet patent suit with Teva; U.K. drug-marketing watchdog calls regs 'very strong';

 @FiercePharma: Which drugs will be pharma's top 2014 blockbusters? Article | Follow @FiercePharma

> Pozen has settled a suit over its Treximet migraine drug with generics maker Teva Pharmaceutical Industries, opening the door to settlements with other drugmakers. Report

> How much is too much to pay for Provenge? Answer

> The head of the panel that monitors the marketing of drugs in the U.K. has defended its system of regulation as being "very strong," despite persistent offenses by one company. Report

> Sanofi-Aventis has a new job for Cressida Ward, its U.K. communications chief. The French drugmaker is bringing Ward to Paris to take a newly created role as promoter of Sanofi's global social work. Report

> The CRO industry poised for recovery--followed by a shakeout. Article

> Blu Pharmaceuticals opens new manufacturing plant in Puerto Rico. Release

> Johnson & Johnson's Pancreaze got the FDA's nod for patients unable to digest and absorb food because they lack the necessary pancreatic enzymes. Report

> Merck never informed Louisiana health officials about the heart-attack risks posed by its withdrawn Vioxx painkiller, a former state agency chief testified in court. Report

> Endo Pharmaceuticals and Penwest Pharmaceuticals settled litigation with Barr Laboratories regarding Barr's plan to sell a generic version of Opana extended-release tablets. Report

> Swiss drugmaker Roche said it bought Elron Electronics' Medingo unit in a deal worth up to $200 million. Report

Biotech News

 @FierceBiotech: Roche: Still looking for deals in 2010. Report | Follow @FierceBiotech

 @JohnCFierce: This Reuters story from Canada makes the U.S. IPO market for biotechs look hot--and it isn't. Report | Follow @JohnCFierce

> Positive MS data may thwart Icahn's plans for Genzyme. Story

> Broadbent tapped as Xcellerex CEO. More

> Novagali talks IPO, takeover by Sanofi. Report

> Aveo gets $5M payment from Biogen Idec. News

Medical Device News

> Should the FDA regulate medical apps? Article

> Boston Sci faces investor lawsuit. Story

> Wake Forest researchers 'print' skin cells. Report

> Medtronic CEO discusses device tax impact. Article

> Study: St. Jude, Medtronic could benefit from Boston Sci woes. News

And Finally... There appears to be no difference among antidepressants in raising a youngster's risk of suicidal thoughts, according to a new long-term study in PediatricsReport

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.